July 20, 2026

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring the 23.86% Potential Upside for Investors

United Therapeutics Corporation (NASDAQ: UTHR) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic drugs. With..

Grifols, S.A. (GRFS) Stock Analysis: Unlocking Potential with a 49.45% Upside

Investors seeking opportunities in the healthcare sector might want to turn their attention to Grifols, S.A. (NASDAQ: GRFS), a Spanish giant in the drug manufacturing industry...

Corcept Therapeutics (CORT) Investor Outlook: Analyzing the 17% Upside Potential

Corcept Therapeutics Incorporated (NASDAQ: CORT) has emerged as a notable player within the biotechnology industry, with a focus on addressing severe endocrinologic, oncologic, metabolic, and neurologic..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Leader Offering 27% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a robust market..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Look at Its 62.57% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is making waves in the biotechnology sector, largely due to its pioneering work in ribonucleic acid interference (RNAi) therapies. As of..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a Challenging Terrain Amidst a 260.20% Revenue Growth

Moderna, Inc. (NASDAQ: MRNA) stands as a prominent player in the biotechnology sector, renowned for its cutting-edge messenger RNA (mRNA) technology, which has been pivotal in..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: A 47.61% Upside Opportunity in Biotech

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) presents an intriguing opportunity for investors with a potential upside of 47.61%, according to analyst consensus. Specializing in the development and..

Veeva Systems Inc. (VEEV) Stock Analysis: A 25% Upside Potential in Healthcare’s Digital Frontier

Veeva Systems Inc. (NYSE: VEEV) stands out as a formidable player in the healthcare sector, offering a diversified suite of cloud-based solutions tailored for the life..

Haleon plc (HLN) Stock Analysis: Unlocking a Potential 15.35% Upside in the Healthcare Sector

Haleon plc (HLN), a leading name in the healthcare sector, has been making waves with its strong market presence and diverse portfolio of consumer healthcare products...

The Cooper Companies, Inc. (COO) Stock Analysis: Unpacking a 13.92% Potential Upside

The Cooper Companies, Inc. (NYSE: COO) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market..

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with a 6.68% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and a promising potential upside..

Chemed Corp (CHE) Stock Analysis: Evaluating the 25.60% ROE in the Healthcare Sector

As an investor with a keen interest in the healthcare sector, focusing on Chemed Corp (NYSE: CHE) could be a prudent move. With a market cap..

Argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 22.61% Upside Potential

For investors eyeing opportunities in the biotechnology sector, argenx SE (NASDAQ: ARGX) stands out as a compelling option. With a market capitalization of $53.84 billion, this..

Fresenius Medical Care AG (FMS) Stock Analysis: Unlocking Potential with a 6.11% Upside

Fresenius Medical Care AG (NYSE: FMS), a stalwart in the healthcare sector, stands out as a global leader in providing dialysis and related services. Headquartered in..

AstraZeneca PLC (AZN) Stock Analysis: Unveiling a 26.64% Potential Upside

AstraZeneca PLC (AZN), a stalwart in the healthcare sector, has long garnered attention for its innovation and robust product pipeline. As a leading entity in the..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 9.86% Potential Upside Amid Robust Therapeutic Portfolio

Biogen Inc. (NASDAQ: BIIB) stands at a pivotal juncture, offering a compelling narrative for investors eyeing opportunities in the healthcare sector. With a market capitalization of..

Solventum Corporation (SOLV) Stock Analysis: Navigating Potential Upside in the Healthcare Sector

Solventum Corporation (SOLV), a key player in the healthcare sector, presents intriguing opportunities for investors seeking exposure to the medical instruments and supplies industry. With a..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth with Strategic Partnerships in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, has positioned itself as a formidable player in the medical distribution industry. With a market..

Quest Diagnostics (DGX) Stock Analysis: A 6.29% Potential Upside in Healthcare Diagnostics

Quest Diagnostics Incorporated (NYSE: DGX), a leading player in the U.S. healthcare diagnostics sector, stands as a compelling consideration for investors seeking exposure to a robust..

Insulet Corporation (PODD) Stock Analysis: Strong Buy Ratings and Potential 45.20% Upside

Insulet Corporation (NASDAQ: PODD) is making waves in the healthcare sector, specifically within the medical devices industry, with its innovative insulin delivery systems. As diabetes management..

Search

Funds

July 20, 2026

Search

Funds

July 20, 2026

FTSE 100

Funds